Publication | Closed Access
Preclinical Studies with JAA-F11 Anti-Thomsen-Friedenreich Monoclonal Antibody for Human Breast Cancer
27
Citations
27
References
2014
Year
The results highlight the potential that humanized JAA-F11 may have for immunotherapy and drug conjugate therapy in breast cancer patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1